| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1812 | 2022 |
| Genome-wide association analysis identifies 13 new risk loci for schizophrenia S Ripke, C O'dushlaine, K Chambert, JL Moran, AK Kähler, S Akterin, ... Nature genetics 45 (10), 1150-1159, 2013 | 1795 | 2013 |
| Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes DM Ruderfer, S Ripke, A McQuillin, J Boocock, EA Stahl, JMW Pavlides, ... Cell 173 (7), 1705-1715. e16, 2018 | 705 | 2018 |
| Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study M Di Forti, A Marconi, E Carra, S Fraietta, A Trotta, M Bonomo, F Bianconi, ... The Lancet Psychiatry 2 (3), 233-238, 2015 | 690 | 2015 |
| Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations RE Peterson, K Kuchenbaecker, RK Walters, CY Chen, AB Popejoy, ... Cell 179 (3), 589-603, 2019 | 651 | 2019 |
| Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders T Singh, MI Kurki, D Curtis, SM Purcell, L Crooks, J McRae, J Suvisaari, ... Nature neuroscience 19 (4), 571-577, 2016 | 458 | 2016 |
| Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users M Di Forti, C Iyegbe, H Sallis, A Kolliakou, MA Falcone, A Paparelli, ... Biological psychiatry 72 (10), 811-816, 2012 | 308 | 2012 |
| The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability T Singh, JTR Walters, M Johnstone, D Curtis, J Suvisaari, M Torniainen, ... Nature genetics 49 (8), 1167-1173, 2017 | 259 | 2017 |
| An examination of polygenic score risk prediction in individuals with first-episode psychosis E Vassos, M Di Forti, J Coleman, C Iyegbe, D Prata, J Euesden, P O’Reilly, ... Biological psychiatry 81 (6), 470-477, 2017 | 250 | 2017 |
| Schizophrenia and influenza at the centenary of the 1918-1919 Spanish influenza pandemic: mechanisms of psychosis risk AP Kępińska, CO Iyegbe, AC Vernon, R Yolken, RM Murray, TA Pollak Frontiers in psychiatry 11, 72, 2020 | 218 | 2020 |
| Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry TB Bigdeli, G Genovese, P Georgakopoulos, JL Meyers, RE Peterson, ... Molecular Psychiatry 25 (10), 2455-2467, 2020 | 122 | 2020 |
| Molecular genetic gene–environment studies using candidate genes in schizophrenia: a systematic review G Modinos, C Iyegbe, D Prata, M Rivera, MJ Kempton, LR Valmaggia, ... Schizophrenia research 150 (2-3), 356-365, 2013 | 115 | 2013 |
| Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis M Colizzi, C Iyegbe, J Powell, G Ursini, A Porcelli, A Bonvino, P Taurisano, ... Schizophrenia bulletin 41 (5), 1171-1182, 2015 | 114 | 2015 |
| Sex-dependent shared and nonshared genetic architecture across mood and psychotic disorders GAM Blokland, J Grove, CY Chen, C Cotsapas, S Tobet, R Handa, ... Biological psychiatry 91 (1), 102-117, 2022 | 106 | 2022 |
| The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research C Iyegbe, D Campbell, A Butler, O Ajnakina, P Sham Social psychiatry and psychiatric epidemiology 49, 169-182, 2014 | 100 | 2014 |
| Cell-and single molecule-based methods to detect anti-N-methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE project J Jézéquel, V Rogemond, T Pollak, M Lepleux, L Jacobson, H Gréa, ... Biological psychiatry 82 (10), 766-772, 2017 | 90 | 2017 |
| Clinical correlates of vitamin D deficiency in established psychosis J Lally, P Gardner-Sood, M Firdosi, C Iyegbe, B Stubbs, K Greenwood, ... BMC psychiatry 16, 1-9, 2016 | 78 | 2016 |
| A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains S Ranlund, S Calafato, JH Thygesen, K Lin, W Cahn, B Crespo‐Facorro, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018 | 77 | 2018 |
| Interplay between schizophrenia polygenic risk score and childhood adversity in first-presentation psychotic disorder: a pilot study A Trotta, C Iyegbe, M Di Forti, PC Sham, DD Campbell, SS Cherny, ... PloS one 11 (9), e0163319, 2016 | 73 | 2016 |
| Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia P Proitsi, MK Lupton, SJ Reeves, G Hamilton, N Archer, BM Martin, ... Neurobiology of aging 33 (4), 791-803, 2012 | 67 | 2012 |
